X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
multiple myeloma (43) 43
hematology (41) 41
humans (40) 40
index medicus (37) 37
male (32) 32
female (31) 31
adult (29) 29
middle aged (29) 29
aged (28) 28
oncology (28) 28
multiple myeloma - drug therapy (18) 18
bortezomib (16) 16
treatment outcome (16) 16
aged, 80 and over (15) 15
antineoplastic combined chemotherapy protocols - therapeutic use (15) 15
multiple myeloma - pathology (15) 15
survival (13) 13
lenalidomide (12) 12
multiple myeloma - mortality (12) 12
dexamethasone (11) 11
survival analysis (11) 11
care and treatment (10) 10
medicine, research & experimental (10) 10
transplantation (10) 10
cancer (9) 9
dexamethasone - administration & dosage (9) 9
disease-free survival (9) 9
prognosis (9) 9
analysis (8) 8
diseases of the blood and blood-forming organs (8) 8
multiple myeloma - diagnosis (8) 8
multiple myeloma - therapy (8) 8
thalidomide (8) 8
antineoplastic agents - therapeutic use (7) 7
bortezomib - administration & dosage (7) 7
chemotherapy (7) 7
diagnosis (7) 7
drug therapy (7) 7
transplantation, autologous (7) 7
treatment (7) 7
adolescent (6) 6
antineoplastic combined chemotherapy protocols - adverse effects (6) 6
combined modality therapy (6) 6
dexamethasone - adverse effects (6) 6
hematology, oncology and palliative medicine (6) 6
kaplan-meier estimate (6) 6
leukemia (6) 6
medical research (6) 6
medicine, experimental (6) 6
mieloma múltiplo (6) 6
multiple myeloma - complications (6) 6
neoplasm staging (6) 6
patients (6) 6
retrospective studies (6) 6
thrombocytopenia (6) 6
clinical trials (5) 5
disease progression (5) 5
double-blind method (5) 5
follow-up studies (5) 5
health risk assessment (5) 5
hydroxamic acids - administration & dosage (5) 5
lbh589 (5) 5
medicine (5) 5
medicine & public health (5) 5
multicenter (5) 5
myeloma (5) 5
panobinostat (5) 5
recurrence (5) 5
relapse (5) 5
safety (5) 5
survival rate (5) 5
therapy (5) 5
anemia (4) 4
antineoplastic combined chemotherapy protocols - administration & dosage (4) 4
autologous transplantation (4) 4
bortezomib - adverse effects (4) 4
brazil (4) 4
carfilzomib (4) 4
cholesterol (4) 4
chronic myeloid leukemia (4) 4
combination (4) 4
combination therapy (4) 4
cyclophosphamide (4) 4
drug administration schedule (4) 4
drug dosages (4) 4
drug resistance, neoplasm (4) 4
emulsions (4) 4
imatinib mesylate (4) 4
indoles - administration & dosage (4) 4
medicine, general & internal (4) 4
neoplasm recurrence, local - drug therapy (4) 4
neoplasm recurrence, local - mortality (4) 4
original article (4) 4
patient outcomes (4) 4
peripheral neuropathy (4) 4
quality of life (4) 4
retreatment (4) 4
stem cell transplantation (4) 4
stem cells (4) 4
young adult (4) 4
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The lancet oncology, ISSN 1470-2045, 2016, Volume 17, Issue 1, pp. 27 - 38
Journal Article
Journal Article
Annals of hematology, ISSN 1432-0584, 2016, Volume 96, Issue 1, pp. 65 - 72
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2013, Volume 14, Issue 11, pp. 1129 - 1140
Journal Article
The lancet oncology, ISSN 1470-2045, 2014, Volume 15, Issue 11, pp. 1195 - 1206
Journal Article
British Journal of Haematology, ISSN 0007-1048, 10/2017, Volume 179, Issue 1, pp. 66 - 74
Journal Article
Journal Article
Journal Article
American Journal of Hematology, ISSN 0361-8609, 10/2012, Volume 87, Issue 10, pp. 948 - 952
Journal Article